Unknown

Dataset Information

Transdermal rotigotine for the perioperative management of restless legs syndrome.


ABSTRACT:

Background

Immobilisation, blood loss, sleep deficiency, and (concomitant) medications during perioperative periods might lead to acute exacerbation of symptoms in patients with the restless legs syndrome (RLS). Continuous transdermal delivery of the dopamine agonist rotigotine provides stable plasma levels over 24 h and may provide RLS patients with a feasible treatment option for perioperative situations. To assess the feasibility of use of rotigotine transdermal patch for the perioperative management of moderate to severe RLS, long-term data of an open-label extension of a rotigotine dose-finding study were retrospectively reviewed.

Methods

The data of all 295 patients who had entered the 5-year study were screened independently by two reviewers for the occurrence of surg

SUBMITTER: Hogl B 

PROVIDER: S-EPMC3577642 | biostudies-literature | 2012 Sep

REPOSITORIES: biostudies-literature